Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Alirocumab by Sanofi for Non-Small Cell Lung Cancer: Likelihood of Approval
Alirocumab is under clinical development by Sanofi and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
Data Insights
Alirocumab by Regeneron Pharmaceuticals for Sepsis: Likelihood of Approval
Alirocumab is under clinical development by Regeneron Pharmaceuticals and currently in Phase I for Sepsis. According to GlobalData, Phase I...